Filing Flows › Exelixis (EXEL) › Q2 2026 › vs Q1 2026
Exelixis (EXEL) Q2 2026 vs Q1 2026 (quarter over quarter)
Exelixis's revenue rose $17.9M (+3%) from $611M in Q1 2026 to $629M in Q2 2026. Operating margin 39.5% against 41.1% (-1.6 pts).
Exelixis, Q2 2026: revenue $629M (+11% year over year), operating margin 39.5%, net earnings $212M, operating cash flow $308M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 39.5% | 41.1% | -1.6 pts |
| Net margin | 33.7% | 34.5% | -0.7 pts |
| Free cash flow margin | 47.9% | 41.0% | +6.9 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $629M | $611M | $17.9M | +3% |
| Other income, net | $14.3M | $16.3M | −$2.1M | -13% |
| Operating profit | $248M | $251M | −$2.9M | -1% |
| Costs & expenses | $380M | $359M | $20.8M | +6% |
| Pre-tax earnings | $263M | $268M | −$5.0M | -2% |
| Cost of revenue | $20.7M | $20.0M | $704K | +4% |
| Research & development | $212M | $200M | $12.1M | +6% |
| SG&A | $148M | $140M | $8.0M | +6% |
| Net earnings | $212M | $210M | $1.6M | +0.8% |
| Income tax | $50.6M | $57.2M | −$6.6M | -12% |
| Depreciation & amortization | $7.0M | $6.9M | $36K | +0.5% |
| Share-based compensation | $32.6M | $29.1M | $3.5M | +12% |
| Working capital & other | $56.1M | $5.4M | $50.8M | +944% |
| Operating cash flow | $308M | $252M | $55.9M | +22% |
| Free cash flow (OCF − capex) | $301M | $250M | $50.6M | +20% |
| Capital expenditures | $6.8M | $1.5M | $5.3M | +352% |
Questions
How much did Exelixis's revenue grow quarter over quarter in Q2 2026?
Exelixis's revenue rose $17.9M (+3%) from $611M in Q1 2026 to $629M in Q2 2026. Operating margin 39.5% against 41.1% (-1.6 pts).